Mouse Polyclonal RBM38 antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human RBM38.
View Alternative Names
RNPC1, SEB4, RBM38, RNA-binding protein 38, CLL-associated antigen KW-5, HSRNASEB, RNA-binding motif protein 38, RNA-binding region-containing protein 1, ssDNA-binding protein SEB4
- WB
Unknown
Western blot - Anti-RBM38 antibody (AB168445)
All lanes:
Western blot - Anti-RBM38 antibody (ab168445) at 1 µg/mL
Lane 1:
Transfected 293T cell lysate at 50 µg
Lane 2:
Non-transfected 293T cell lysate at 50 µg
Secondary
All lanes:
Goat Anti-mouse HRP at 1/2500 dilution
Predicted band size: 25 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RBM38 participates in post-transcriptional regulation modulating the stability and translation of messenger RNAs (mRNAs). It does not function alone but associates with other ribonucleoprotein complexes to achieve its regulatory roles. Through its binding activity RBM38 can influence cell cycle progression and apoptosis by regulating mRNAs such as p53 and p21 which are key players in cell fate decisions.
Pathways
RBM38 is involved in the p53 signaling pathway which plays a critical role in cell cycle control and response to DNA damage. It associates with proteins like Mdm2 and p21 which are vital components of this pathway. Additionally RBM38 interacts with the MAPK pathway which is important for regulating responses to various extracellular stimuli and ensuring proper cellular functions like proliferation and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Molecular medicine (Cambridge, Mass.) 31:136 PubMed40234753
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular oncology (Dordrecht) 46:1493-1507 PubMed37219768
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com